// App-Quantinova.ai

: Racial, Ethnic, and Socioeconomic Factors Result in Disparities in Outcome Among Children with Acute Lymphoblastic Leukemia Not Fully Attenuated By Disease Prognosticators: A Children's Oncology Group (COG) Study

Researchers

Presenter

  • Sumit Gupta

Principal Investigators

  • Meenakshi Devidas

  • Yunfeng Dai

  • Richard Aplenc

  • Lena Winestone

  • Kira O Bona

  • Karen R Rabin

  • Patrick A Zweidler-McKay

  • Kelly W Maloney

  • Leonard A. Mattano

  • Eric C Larsen

  • Anne L Angiolillo

  • Reuven J Schore

  • Michael J. Burke

  • Wanda L Salzer

  • Stuart S. Winter

  • Kimberly P. Dunsmore

  • Naomi J Winick

  • William L. Carroll

  • Stephen P Hunger

  • Mignon L. Loh

Medical Centers

  • Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA

  • Department of Pediatrics, Carilion Clinic Children's Hospital, Roanoke, VA

  • Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California Benioff Children's Hospital, San Francisco, CA

  • Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada

  • Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

  • Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Rutledge, PA

  • Baylor College of Medicine TX Children's Cancer Center, Houston, TX

  • CHILDREN'S HOSPITAL OF PHILADELPHIA, PHILADELPHIA, PA

  • Department of Pediatrics, Division of Pediatric Hematology/Oncology/BMT, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO

  • Children's National Health System/George Washington University SMHS, Washington, DC

  • U.S. Army Medical Research and Materiel Command, Olney, MD

  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA

  • Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX

  • Division of Oncology, University of Virginia Children's Hospital, Charlottesville, VA

  • Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME

  • Department of Biostatistics, University of Florida, Gainesville, FL

  • Department of Pediatrics, Harvard Medical School, Boston, MA

  • Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN

  • Immunogen, Waltham, MA

  • Children's Minnesota Research Institute and Cancer and Blood Disorders Program, Minneapolis, MN

  • Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, Canada

  • Faculty of Medicine, University of Toronto, Toronto, Canada

  • Virginia Tech Carilion School of Medicine, Roanoke, VA

  • Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA

  • Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, Perlmutter Cancer Center at NYU Langone Health, New York University, New York, NY

  • Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A